Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.475
+0.025 (1.72%)
Mar 4, 2026, 2:32 PM EST - Market open

Lucid Diagnostics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
203667279270-
Market Cap Growth
150.87%-8.14%-9.74%-70.61%--
Enterprise Value
176.29119.1186.6158.88216.360
Last Close Price
1.480.821.411.365.37-
PE Ratio
--0.94-1.34-1.52-5.12-
PS Ratio
45.5415.1429.50210.48540.03-
PB Ratio
7.7512.20-30.993.444.93-
P/TBV Ratio
4.949.21-30.573.690.00-
P/FCF Ratio
--1.48-2.17-2.59-14.57-
P/OCF Ratio
--1.49-2.18-2.67-15.28-
EV/Sales Ratio
40.0727.4135.67156.17432.71-
EV/EBITDA Ratio
--2.65-1.88-1.08-7.89-
EV/EBIT Ratio
--2.59-1.79-1.05-7.89-
EV/FCF Ratio
--2.68-2.62-1.92-11.68-
Debt / Equity Ratio
0.943.94-6.600.0900
Debt / EBITDA Ratio
-0.52-0.47-0.33-0.04--
Debt / FCF Ratio
-0.55-0.48-0.46-0.06--
Net Debt / Equity Ratio
-0.89-0.201.58-0.89-0.980.01
Net Debt / EBITDA Ratio
0.490.030.080.381.960.01
Net Debt / FCF Ratio
0.520.030.110.672.900.02
Asset Turnover
0.100.150.080.010.020
Inventory Turnover
16.8222.9430.7465.12--
Quick Ratio
1.830.950.642.6712.640.01
Current Ratio
1.901.070.752.8913.450.09
Return on Equity (ROE)
-341.29%-2956.43%-507.97%-144.42%-136.23%87.96%
Return on Assets (ROA)
-114.42%-158.84%-162.20%-122.94%-89.61%-512.87%
Return on Invested Capital (ROIC)
-1347.51%-1200.21%-888.03%-1095.23%-2311.89%3226.45%
Return on Capital Employed (ROCE)
-280.87%-1813.43%-441.31%-142.73%-133.03%87.96%
Earnings Yield
-32.87%-106.88%-74.47%-65.96%-19.53%-
FCF Yield
-22.06%-67.54%-46.13%-38.55%-6.86%-
Buyback Yield / Dilution
-36.40%-0.69%-1.17%-3.29%-25.92%-
Updated Nov 12, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q